Asacol 400Mg 100 Tablets
A delayed-release oral wafer designed to deliver mesalazine directly to the colon, reducing inflammation in ulcerative colitis while minimizing systemic absorption.
Indications:
- Management of mild to moderate ulcerative colitis flares.
- Maintenance therapy to help prevent relapse in ulcerative colitis.
- Treatment of crohn's disease.
Main Active Ingredient:
- Mesalazine (each tablet 400 mg).
Precautions:
- Not for use in case of known sulfa or mesalazine allergy.
- Caution in patients with kidney or liver disease, and those with blood disorders.
- Regular monitoring of blood counts, renal and hepatic function advisable.
- Notify your doctor if pregnant, planning pregnancy, or breastfeeding.
- Store in original packaging at room temperature, away from moisture and children.
Side Effects:
- Most commonly: nausea, headache, abdominal discomfort.
- Possible local irritation or mild allergic reactions.
Drug–Drug Interactions:
- Warfarin and other anticoagulants.
- NSAIDs.
- Azathioprine or 6-mercaptopurine.
Indications:
- Management of mild to moderate ulcerative colitis flares.
- Maintenance therapy to help prevent relapse in ulcerative colitis.
- Treatment of crohn's disease.
Main Active Ingredient:
- Mesalazine (each tablet 400 mg).
Precautions:
- Not for use in case of known sulfa or mesalazine allergy.
- Caution in patients with kidney or liver disease, and those with blood disorders.
- Regular monitoring of blood counts, renal and hepatic function advisable.
- Notify your doctor if pregnant, planning pregnancy, or breastfeeding.
- Store in original packaging at room temperature, away from moisture and children.
Side Effects:
- Most commonly: nausea, headache, abdominal discomfort.
- Possible local irritation or mild allergic reactions.
Drug–Drug Interactions:
- Warfarin and other anticoagulants.
- NSAIDs.
- Azathioprine or 6-mercaptopurine.
$11.80
Original: $39.33
-70%Asacol 400Mg 100 Tablets—
$39.33
$11.80Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
A delayed-release oral wafer designed to deliver mesalazine directly to the colon, reducing inflammation in ulcerative colitis while minimizing systemic absorption.
Indications:
- Management of mild to moderate ulcerative colitis flares.
- Maintenance therapy to help prevent relapse in ulcerative colitis.
- Treatment of crohn's disease.
Main Active Ingredient:
- Mesalazine (each tablet 400 mg).
Precautions:
- Not for use in case of known sulfa or mesalazine allergy.
- Caution in patients with kidney or liver disease, and those with blood disorders.
- Regular monitoring of blood counts, renal and hepatic function advisable.
- Notify your doctor if pregnant, planning pregnancy, or breastfeeding.
- Store in original packaging at room temperature, away from moisture and children.
Side Effects:
- Most commonly: nausea, headache, abdominal discomfort.
- Possible local irritation or mild allergic reactions.
Drug–Drug Interactions:
- Warfarin and other anticoagulants.
- NSAIDs.
- Azathioprine or 6-mercaptopurine.
Indications:
- Management of mild to moderate ulcerative colitis flares.
- Maintenance therapy to help prevent relapse in ulcerative colitis.
- Treatment of crohn's disease.
Main Active Ingredient:
- Mesalazine (each tablet 400 mg).
Precautions:
- Not for use in case of known sulfa or mesalazine allergy.
- Caution in patients with kidney or liver disease, and those with blood disorders.
- Regular monitoring of blood counts, renal and hepatic function advisable.
- Notify your doctor if pregnant, planning pregnancy, or breastfeeding.
- Store in original packaging at room temperature, away from moisture and children.
Side Effects:
- Most commonly: nausea, headache, abdominal discomfort.
- Possible local irritation or mild allergic reactions.
Drug–Drug Interactions:
- Warfarin and other anticoagulants.
- NSAIDs.
- Azathioprine or 6-mercaptopurine.
